Doc. MUDr. Alena Paříková, Ph.D.

Chin HJ, Chae DW, Kim YC, et al. Comparison of the Efficacy and Safety of Tacrolimus and Low‑Dose Corticosteroid with High‑Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults. J Am Soc Nephrol 2021;32:199–210.

Rondeau E, Scully M, Ariceta G, et al.; 311 Study Group. The long‑acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment. Kidney Int 2020;97:1287–1296.

Macdougall IC, Bhandari S, White C, et al.; PIVOTAL Investigators and Committees. Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial. J Am Soc Nephrol 2020;31:1118–1127.

Parikh CH, Liu C, Mor MK, et al. Kidney Biomarkers of Injury and Repair as Predictors of Contrast‑Associated AKI: A Substudy of the PRESERVE Trial. Am J Kidney Dis 2020;75:187–194.

Soveri I, Molne J, Uhlin F, et al. The IgG‑degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti‑glomerular basement membrane antibodies in patients with refractory anti‑glomerular basement membrane disease. Kidney Int 2019;96:1234–1238.

Le Clech A, Simon‑Tillaux N, Provôt F, et al. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors. Kidney Int 2019;95:1443–1452.

Luciano RL, Moeckel GW. Update on the Native Kidney Biopsy: Core Curriculum 2019.

Am J Kidney Dis 2019;73:404–415.

Krediet RT. Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.

Front Physiol 2018;9:1815.

Schaefer F, Ardissino G, Ariceta G, et al.;

Global aHUS Registry. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

Kidney Int 2018;94:408–418.

See EJ, Johnson DW, Hawley CM, et al.

Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study. Am J Kidney Dis 2018;72:188–197.

Cullaro G, Park M, Lai JC.

“Normal” Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients with Cirrhosis. Hepatology 2018 Apr 26. doi: 10.1002/hep.30058. [Epub ahead of print]

Al‑Jaghbeer M, Dealmeida D, Bilderback A, et al.

Clinical Decision Support for In‑Hospital AKI. J Am Soc Nephrol 2018;29:654–660.

Ravel VA, Streja E, Mehrotra E, et al.
Serum sodium and mortality in a national peritoneal dialysis cohort. Nephrol Dial Transplant 2017;32:1224–1233.

Wilhelm‑Leen E, Montez‑Rath ME, Chertow G.
Estimating the Risk of Radiocontrast‑Associated Nephropathy. J Am Soc Nephrol 2017;28:653–659.

Keskar V, McArthur E, Wald R, et al.
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. Kidney Int 2017; in press.

Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, Robinson BM, Sunder‑Plassmann G, Port FK. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2012;59:238–248.